Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
SiriusXM
SIRI
$9.43B
| $11.5M | ﹤0.01% |
575,697
+336,269
| +140% | +$7.23M |
|
1577
CACI
CACI
$14.8B
| $11.5M | ﹤0.01% |
21,579
-31,137
| -59% | -$17.6M |
|
1578
Columbia Banking Systems
COLB
$9.18B
| $11.5M | ﹤0.01% |
411,049
-1,050,822
| -72% | -$28.4M |
|
1579
Modine Manufacturing
MOD
$10.8B
| $11.5M | ﹤0.01% |
86,027
+8,659
| +11% | +$1.29M |
|
1580
Seaboard Corp
SEB
$4.08B
| $11.5M | ﹤0.01% |
2,580
-116
| -4% | -$459K |
|
1581
ONE Gas
OGS
$5.09B
| $11.4M | ﹤0.01% |
148,072
-21,243
| -13% | -$1.71M |
|
1582
PUT
Marathon Petroleum
MPC
$100B
| $11.4M | ﹤0.01% |
70,300
| – | – |
|
1583
Cogent Biosciences
COGT
$6.47B
| $11.4M | ﹤0.01% |
321,606
-38,224
| -11% | -$1.07M |
|
1584
CALL
Avis
CAR
$4.84B
| $11.4M | ﹤0.01% |
89,000
+400
| +0.5% | +$55.8K |
|
1585
HubSpot
HUBS
$12B
| $11.4M | ﹤0.01% |
28,435
+4,361
| +18% | +$1.81M |
|
1586
CALL
e.l.f. Beauty
ELF
$5.43B
| $11.4M | ﹤0.01% |
150,000
| – | – |
|
|
1587
PUT
e.l.f. Beauty
ELF
$5.43B
| $11.4M | ﹤0.01% |
150,000
| – | – |
|
1588
Black Hills Corp
BKH
$5.64B
| $11.4M | ﹤0.01% |
164,079
-2,298
| -1% | -$155K |
|
1589
BCE
BCE
$21.7B
| $11.4M | ﹤0.01% |
477,586
+174,082
| +57% | +$4.05M |
|
1590
Arcosa
ACA
$7.12B
| $11.4M | ﹤0.01% |
106,915
+12,630
| +13% | +$1.27M |
|
1591
Enovix
ENVX
$966M
| $11.3M | ﹤0.01% |
1,551,941
+1,124,480
| +263% | +$10.9M |
|
1592
CALL
American International
AIG
$39.8B
| $11.3M | ﹤0.01% |
+132,500
| New | +$10.6M |
|
1593
CALL
Vanguard FTSE Emerging Markets ETF
VWO
$126B
| $11.3M | ﹤0.01% |
210,700
+57,200
| +37% | +$3.11M |
|
1594
New York Times
NYT
$10.3B
| $11.3M | ﹤0.01% |
163,089
-59,383
| -27% | -$3.68M |
|
1595
Toast
TOST
$20.4B
| $11.3M | ﹤0.01% |
318,804
+40,218
| +14% | +$1.45M |
|
|
KALV
1596
DELISTED
KalVista Pharmaceuticals
KALV
| $11.3M | ﹤0.01% |
700,573
+122,669
| +21% | +$1.62M |
|
1597
Trupanion
TRUP
$1.36B
| $11.3M | ﹤0.01% |
302,625
-77,267
| -20% | -$3.03M |
|
1598
Atour Lifestyle Holdings
ATAT
$4.5B
| $11.3M | ﹤0.01% |
286,805
+204,186
| +247% | +$8M |
|
1599
Quantum Computing Inc
QUBT
$2.02B
| $11.3M | ﹤0.01% |
1,100,974
+851,034
| +340% | +$12.1M |
|
1600
KBR
KBR
$4.81B
| $11.3M | ﹤0.01% |
280,984
+111,303
| +66% | +$4.77M |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.